ÂÜÀòÂÒÂ×

Beth Ollington, PhD, is a Cell Therapy Process Development Scientist at Anthony Nolan since June 2023. Prior to that, Beth worked as a Postdoctoral Research Associate at UCL from January 2022 to January 2023. Beth completed their MRC DiMeN PhD at The University of Sheffield from October 2017 to September 2021. Beth obtained their PhD in Immunology from The University of Sheffield in April 2022 after completing their Master's degree in Biological Chemistry and Drug Discovery at the University of Dundee from 2012 to 2017. Beth began their academic journey at Havering Sixth Form College from 2009 to 2011, followed by The Albany Business and Enterprise College from 2004 to 2009.